- Home
- INM vs UOKA Comparison
INM vs UOKA Comparison
Compare INM & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- UOKA
- Stock Information
- Founded
- INM 1981
- UOKA 2002
- Country
- INM Canada
- UOKA United Kingdom
- Employees
- INM N/A
- UOKA N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- INM Health Care
- UOKA
- Exchange
- INM Nasdaq
- UOKA NYSE
- Market Cap
- INM 2.3M
- UOKA 2.6M
- IPO Year
- INM N/A
- UOKA N/A
- Fundamental
- Price
- INM $3.12
- UOKA $0.17
- Analyst Decision
- INM
- UOKA
- Analyst Count
- INM 0
- UOKA 0
- Target Price
- INM N/A
- UOKA N/A
- AVG Volume (30 Days)
- INM 84.1K
- UOKA 27.2M
- Earning Date
- INM 02-12-2025
- UOKA 03-04-2025
- Dividend Yield
- INM N/A
- UOKA N/A
- EPS Growth
- INM N/A
- UOKA N/A
- EPS
- INM N/A
- UOKA N/A
- Revenue
- INM $4,832,013.00
- UOKA $114,849.00
- Revenue This Year
- INM N/A
- UOKA N/A
- Revenue Next Year
- INM N/A
- UOKA N/A
- P/E Ratio
- INM N/A
- UOKA N/A
- Revenue Growth
- INM N/A
- UOKA 289.97
- 52 Week Low
- INM $2.42
- UOKA $0.13
- 52 Week High
- INM $15.70
- UOKA $1.80
- Technical
- Relative Strength Index (RSI)
- INM 37.82
- UOKA N/A
- Support Level
- INM $3.03
- UOKA N/A
- Resistance Level
- INM $3.48
- UOKA N/A
- Average True Range (ATR)
- INM 0.20
- UOKA 0.00
- MACD
- INM 0.05
- UOKA 0.00
- Stochastic Oscillator
- INM 35.59
- UOKA 0.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.